2nd Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$142,079
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 15, 2015 $142,079 Replaced
2nd Quarter - Amendment Jul 31, 2015 $142,079 Yes

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Education EDU

Student Loan Financing and Re-Financing

LobbyistCovered position, as disclosed
RAY QUINTERO Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Public Policy Associate
LAURA WOOSTER Associate Vice President Public Policy

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); White House Office; Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); Executive Office of the President (EOP); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC)

Budget/Appropriations BUD

Labor HHS Appropriations

LobbyistCovered position, as disclosed
RAY QUINTERO Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Public Policy Associate
LAURA WOOSTER Associate Vice President Public Policy

Contacted: Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Government Accountability Office (GAO); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); Executive Office of the President (EOP); White House Office

Insurance INS

Health Insurance; Professional Liability Insurance; State Insurance Marketplace

LobbyistCovered position, as disclosed
RAY QUINTERO Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Public Policy Associate
LAURA WOOSTER Associate Vice President Public Policy

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); White House Office; SENATE; Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); Executive Office of the President (EOP)

Medical/Disease Research/Clinical Labs MED

NIH; FDA; Agency for Health Care Quality & Research Funding

LobbyistCovered position, as disclosed
RAY QUINTERO Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Public Policy Associate
LAURA WOOSTER Associate Vice President Public Policy

Contacted: Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Government Accountability Office (GAO); Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); SENATE; Food & Drug Administration (FDA)

Torts TOR

Professional Liability Insurance; Medical Liability Reform

LobbyistCovered position, as disclosed
RAY QUINTERO Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Public Policy Associate
LAURA WOOSTER Associate Vice President Public Policy

Contacted: Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); SENATE; Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Government Accountability Office (GAO)

Defense DEF

Recognition of Osteopathic Certification

LobbyistCovered position, as disclosed
RAY QUINTERO Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Public Policy Associate
LAURA WOOSTER Associate Vice President Public Policy

Contacted: Government Accountability Office (GAO); Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); SENATE; Medicare Payment Advisory Commission (MedPAC); White House Office; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC)

Taxation/Internal Revenue Code TAX

Flexible Spending Accounts; Health Savings Accounts

LobbyistCovered position, as disclosed
RAY QUINTERO Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Public Policy Associate
LAURA WOOSTER Associate Vice President Public Policy

Contacted: Office of Management & Budget (OMB); Government Accountability Office (GAO); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); White House Office; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE; Health Resources & Services Administration (HRSA)

Health Issues HCR

Medicare Physician Payments Reform, Patient access to care; Graduate Medical Education; Physician Workforce Issues; Health reform implementation (PL 111-148); Telehealth (Health Information Technology)

LobbyistCovered position, as disclosed
RAY QUINTERO Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Public Policy Associate
LAURA WOOSTER Associate Vice President Public Policy

Contacted: Health & Human Services, Dept of (HHS); White House Office; Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); SENATE; Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC)

Medicare/Medicaid MMM

Graduate Medical Education; Health Care Quality, Patient Access to Health Care; Physician Workforce; Medicare Physician Payment Issues; Independent Payment Advisory Board. H.R. 574, The Medicare Physician Payment Innovation Act of 2013.

LobbyistCovered position, as disclosed
RAY QUINTERO Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Public Policy Associate
LAURA WOOSTER Associate Vice President Public Policy

Contacted: Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); SENATE; White House Office; Executive Office of the President (EOP); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 574 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.